Brief Illness, Haunting Effects: Gestational Diabetes and the Spectrality of Care

Anne-Sophie Guernon1

  • 1Department of Anthropology, McGill University, Montreal, Canada. anne-sophie.guernon@mail.mcgill.ca.

PubMed

This article interrogates the diagnostic category of gestational diabetes mellitus (GDM) as a spectral illness, that is transitory, affectively charged, and shaped by regimes of anticipation and surveillance. Drawing on six months of ethnographic fieldwork in Vancouver hospitals, I trace how GDM is enacted not through embodied symptoms but through numerical thresholds, creating a clinical reality that arrives unannounced and often departs before it is ever felt. Despite its apparent disappearance, GDM leaves behind lingering traces: haunting fears of the return of chronic illness, maternal guilt, residual disordered eating tendencies, and the specter of intergenerational risk. Through a conceptual framework that brings together Derrida's notions of the hauntology, spectres, ghosts, and revenants; Fischer's temporal disjunctions of the "no longer" and the "not yet"; and other theories of 'at-riskness' and surveillance in medicine, I argue that GDM initiates a haunting that reconfigures the experience of pregnancy. It summons past traumas, elicits future-oriented anxieties, and embeds the maternal body within a terrain of ongoing clinical and moral oversight. As a diagnosis with a temporal expiration but lasting affective and embodied consequences, GDM demands new analytic attention to how biomedicine produces and manages uncertainty, anticipation, spectrality, and haunting.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.9K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
861
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
826